These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4992010)

  • 61. [Study of Iskedyl in otoneurologic ischemia].
    Duchamps B
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):649-53. PubMed ID: 4280429
    [No Abstract]   [Full Text] [Related]  

  • 62. [Study of the association of raubasine and dihydroergocristine in the aged patient with vascular disease].
    Sauter R
    Lille Med; 1971; 17():Suppl 3:551-8. PubMed ID: 5005074
    [No Abstract]   [Full Text] [Related]  

  • 63. [Trial of a new central and peripheral vaso-regulator therapeutic agent: DF 69].
    Laveant-Hebrard C; Camus JP
    Therapeutique; 1970 Oct; 46(8):805-6. PubMed ID: 4989868
    [No Abstract]   [Full Text] [Related]  

  • 64. [On the behavior of cerebrovascular resistance under the influence of sympatholytics].
    Klein K; Siedek H
    Wien Med Wochenschr; 1966 Jan; 116(1):20-2. PubMed ID: 4962461
    [No Abstract]   [Full Text] [Related]  

  • 65. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine].
    Henriet M; Jacquy J; Noel G
    Brux Med; 1974 Dec; 54(12):743-5. PubMed ID: 4215548
    [No Abstract]   [Full Text] [Related]  

  • 66. [Observations during ambulatory therapy of functional and organic circulatory disorders with Defluina].
    Brüning G
    Med Welt; 1975 Sep; 26(38):1737-41. PubMed ID: 810634
    [No Abstract]   [Full Text] [Related]  

  • 67. Electroencephalogram and ergot alkaloids.
    Venn RD
    Postgrad Med J; 1976; 52suppl 1():55-6. PubMed ID: 822408
    [No Abstract]   [Full Text] [Related]  

  • 68. Hydergine for treatment of symptoms of cerebrovascular insufficiency.
    Triboletti F; Ferri H
    Curr Ther Res Clin Exp; 1969 Oct; 11(10):609-20. PubMed ID: 4981305
    [No Abstract]   [Full Text] [Related]  

  • 69. [Electroencephalographic alterations after administration of vaso-active substance (Hydergine)].
    Pires de Oliveira RS
    Arq Neuropsiquiatr; 1973 Jun; 31(2):107-22. PubMed ID: 4198581
    [No Abstract]   [Full Text] [Related]  

  • 70. [On the use of vitamin E nicotinate in cerebral diseases caused by debilitation].
    Poggi E; Sforzini D; Tosarelli L
    Sist Nerv; 1971; 23(7):126-32. PubMed ID: 5005842
    [No Abstract]   [Full Text] [Related]  

  • 71. [Cerebral rheography].
    Perbellini D; Zuanazzi GF
    Riv Sper Freniatr Med Leg Alien Ment; 1969 Jun; 93(3):784-94. PubMed ID: 4982870
    [No Abstract]   [Full Text] [Related]  

  • 72. [Therapy of cerebral ictus yesterday and today].
    Giorgini R
    Minerva Med; 1974 Mar; 65(24):1316-21. PubMed ID: 4133959
    [No Abstract]   [Full Text] [Related]  

  • 73. [The premonitory signs of severe cerebrovascular accidents].
    Rouzaud M; Glories P; Degiovanni E
    Sem Hop; 1971 Dec; 47(53):3073-8. PubMed ID: 4336338
    [No Abstract]   [Full Text] [Related]  

  • 74. [On the symptomatology and therapy of cerebral arteriosclerosis in general practice].
    Michaelis U
    Ther Ggw; 1966 Dec; 105(12):1593-600. PubMed ID: 4962890
    [No Abstract]   [Full Text] [Related]  

  • 75. [Influence of hydergine in the vertebro-basilar vascular insufficiency syndrome of cervical origin].
    Sánchez Dueñas M
    Rev Esp Otoneurooftalmol Neurocir; 1970; 28(161):41-6. PubMed ID: 4999170
    [No Abstract]   [Full Text] [Related]  

  • 76. An ergot alkaloid preparation (hydergine) in geriatric therapy.
    Roubicek J; Geiger C; Abt K
    J Am Geriatr Soc; 1972 May; 20(5):222-9. PubMed ID: 4623679
    [No Abstract]   [Full Text] [Related]  

  • 77. [Apropos of some symptomatic aspects of ischemic phenomena of the vertebro-basilar circulation].
    Ambrosetto C; Rebucci GG; Gambi D
    Riv Otoneurooftalmol; 1966; 41(6):599-611. PubMed ID: 5998153
    [No Abstract]   [Full Text] [Related]  

  • 78. [Control of cerebral blood circulation time during long-term Wallerox therapy. Measurements using external scintillation counters].
    Herzfeld U; Erbe H
    Med Welt; 1971 Nov; 48(71):1933-5. PubMed ID: 5002422
    [No Abstract]   [Full Text] [Related]  

  • 79. [The combined coronary and cerebral syndrome. Clinical study].
    De' Thomatis M
    Arch Maragliano Patol Clin; 1970; 26(1):47-73. PubMed ID: 5467886
    [No Abstract]   [Full Text] [Related]  

  • 80. [Clinical test using Brinaldix plus Hydergine].
    Elizalde JE
    Hospital (Rio J); 1967 Dec; 72(6):1941-2. PubMed ID: 4983683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.